Valuation : Bausch + Lomb Corporation

Market Cap 6.16B 5.31B 5.03B 4.56B 8.55B 589B 8.59B 59.7B 22.96B 299B 23.14B 22.63B 946B P/E 2026 *
-283x
P/E 2027 * 44.8x
Enterprise Value 10.61B 9.14B 8.65B 7.84B 14.71B 1,013B 14.79B 103B 39.52B 516B 39.83B 38.96B 1,629B EV / Sales 2026 *
1.93x
EV / Sales 2027 * 1.78x
Free-Float
12.7%
Yield 2026 *
-
Yield 2027 * -

Last Transcript : Bausch + Lomb Corporation

1 day-1.71%
1 week-4.38%
Current month-1.32%
1 month+2.25%
3 months+12.82%
6 months-1.43%
Current year+1.00%
1 week 17.01
Extreme 17.01
18.2
1 month 16.6
Extreme 16.6
18.46
Current year 14.65
Extreme 14.65
18.92
1 year 13.76
Extreme 13.765
18.92
3 years 10.45
Extreme 10.45
21.69
5 years 10.45
Extreme 10.45
21.95
10 years 10.45
Extreme 10.45
21.95
Manager TitleAgeSince
Chief Executive Officer 56 2023-03-05
Director of Finance/CFO 53 2021-12-31
Chief Tech/Sci/R&D Officer 59 2022-01-30
Director TitleAgeSince
Director/Board Member 62 2021-12-31
Director/Board Member 69 2022-04-30
Director/Board Member 78 2022-03-31
Date Insider Type Main position Quantity % Market Cap. Importance
8/12/26 Free

Director

11,776 0.0033%
8/12/26 Option

Director

11,776 0.0033%
8/12/26 Free

Director

11,776 0.0033%
Change 5-day change 1-year change 3-year change Capi.($)
-1.71%-4.38%+12.60%-2.32% 6.27B
-1.36%-5.89%-23.14%-0.49% 179B
-0.72%-3.41%-3.49%+11.74% 117B
+0.19%-2.83%+6.20%+80.93% 61.25B
-1.92%-7.24%+9.51%+41.28% 50.24B
+0.81%-3.73%-6.67%-33.43% 48.05B
-1.75%-5.54%+9.25%-22.61% 31.89B
+0.43%-11.10% - - 28.42B
+0.58%+1.84%+31.28%-12.82% 24.23B
+0.49%-8.98%-13.28%+5.27% 21.4B
Average -0.50%-4.98%+2.47%+7.51% 56.78B
Weighted average by Cap. -0.71%-4.23%-5.87%+10.72%

Financials

2026 *2027 *
Net sales 5.49B 4.73B 4.48B 4.06B 7.62B 525B 7.66B 53.24B 20.47B 267B 20.63B 20.18B 844B 5.82B 5.01B 4.75B 4.3B 8.07B 556B 8.11B 56.36B 21.67B 283B 21.84B 21.36B 893B
Net income -60.83M -52.41M -49.63M -44.98M -84.39M -5.81B -84.81M -589M -227M -2.96B -228M -223M -9.34B 131M 113M 107M 97.06M 182M 12.54B 183M 1.27B 489M 6.38B 493M 482M 20.16B
Net Debt 4.45B 3.83B 3.63B 3.29B 6.17B 425B 6.2B 43.07B 16.56B 216B 16.7B 16.33B 683B 4.17B 3.59B 3.4B 3.08B 5.78B 398B 5.81B 40.39B 15.53B 203B 15.66B 15.31B 640B
Logo Bausch + Lomb Corporation
Bausch + Lomb Corporation is an eye health company. It operates through three segments: Vision Care, Pharmaceuticals, and Surgical. Vision Care segment includes both a contact lens and a consumer eye care business that consists of contact lens care products, over-the-counter eye drops and eye vitamins. Pharmaceuticals segment consists of generic pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. Surgical segment consists of medical device equipment, consumables, instruments and technologies for the treatment of cataracts, corneal and vitreous and retinal eye conditions, which includes delivery systems, phacoemulsification equipment and other surgical instruments and devices for cataract surgery. Its brands consist of PreserVision, Biotrue, Artelac, Alaway, Mioclear, Ocuvite, ScoutPro, XIIDRA, Vyzulta, Lotemax, Prolensa, Minims, INFUSE, and many more.
Employees
13,000
Date Price Change Volume
26-09-11 US$17.25 -1.71% 460,175
26-09-10 US$17.55 -1.35% 521,450
26-09-09 US$17.79 +0.34% 484,926
26-09-08 US$17.73 -1.72% 335,608
26-09-04 US$18.04 -0.55% 414,107
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
17.25USD
Average target price
19.04USD
Spread / Average Target
+10.37%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BLCO Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!